Biocom’s Terri Somers is out with the latest Deals and Data.

This issue highlights our story on the issue of biosimilars and the battle going on in Washington D.C.

It also links to news on new National Institutes of Health guidelines on stem cells, and Xconomy’s chat with a couple of angel investors.


Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.